Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription 09.07.2018 1 Ann Thorac Surg 3 Anticancer Res 2 BMC Cancer 1 Cancer Sci 1 Clin Cancer Res 1 J Thorac Oncol 1 Lung Cancer 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Thorac Surg

1. CAO J, Hu J
   Recording Margin Distance is Crucial in Limited Pulmonary Resection for Lung Cancer (Reply).
   Ann Thorac Surg. 2018 Jun 30. pii: S0003-4975(18)30898.
   PubMed     Text format    
   
   

   
   Anticancer Res

2. BAXA J, Matouskova T, Ludvik J, Sedlmair M, et al
   Single-source Dual-energy CT as a Part of (18)F-FDG PET/CT: Direct Comparison of Iodine-related and Metabolic Parameters in Non-small Cell Lung Cancer.
   Anticancer Res. 2018;38:4131-4137.
   PubMed     Text format     Abstract available
   
   
3. SCHMID S, Csanadi A, Kozhuharov N, Tchudjin M, et al
   CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
   Anticancer Res. 2018;38:3913-3918.
   PubMed     Text format     Abstract available
   
   
4. MAIUTHED A, Chantarawong W, Chanvorachote P
   Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
   Anticancer Res. 2018;38:3797-3809.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

5. HIGUCHI Y, Motoki T, Ishida H, Kanamitsu K, et al
   Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
   BMC Cancer. 2017;17:775.
   PubMed     Text format     Abstract available
   
   
6. SHENG Y, Xu M, Li C, Xiong Y, et al
   Nm23-H1 is involved in the repair of ionizing radiation-induced DNA double-strand breaks in the A549 lung cancer cell line.
   BMC Cancer. 2018;18:710.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Sci

7. MURAKAMI H, Nokihara H, Hayashi H, Seto T, et al
   Clinical activity of ASP8273 in Asian patients with non-small cell lung cancer with EGFR activating and T790M mutations.
   Cancer Sci. 2018 Jul 4. doi: 10.1111/cas.13724.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

8. ROMANIELLO D, Mazzeo L, Mancini M, Marrocco I, et al
   A Combination Of Approved Antibodies Overcomes Resistance Of Lung Cancer To Osimertinib By Blocking Bypass Pathways.
   Clin Cancer Res. 2018 Jul 2. pii: 1078-0432.CCR-18-0450.
   PubMed     Text format     Abstract available
   
   

   
   J Thorac Oncol

9. WU YL, Lu S, Lu Y, Zhou J, et al
   Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.
   J Thorac Oncol. 2018 Jun 29. pii: S1556-0864(18)30721.
   PubMed     Text format     Abstract available
   
   

   
   Lung Cancer

10. ANDREAS S, Chouaid C, Danson S, Siakpere O, et al
    Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Lung Cancer. 2018 Jun 9. pii: S0169-5002(18)30416.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

11. ROTH JA, Carter-Harris L, Brandzel S, Buist DSM, et al
    A qualitative study exploring patient motivations for screening for lung cancer.
    PLoS One. 2018;13:e0196758.
    PubMed     Text format     Abstract available
    
    
12. HEIDEN BT, Chen G, Hermann M, Brown RKJ, et al
    18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
    PLoS One. 2018;13:e0199970.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: